IBD Flashcards

1
Q

What is IBD

A

High inflammation of the large intestine. Comes along is a high relapse rate (chance of getting it again and again).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the contraction like in the large intestines?

A

Contraction is more propulsive in small intestine, in large intestine it’s more of squeezing type (think of a bin bag with strings where you pull them and contracts the ends). Bends in the large intestine is where food and unwanted material can become concentrated, contraction is important here to move these along.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Where can IBD be diagnosed in the large intestine?

A

Crohn’s mainly occurs in the initial part of the ascending colon, then center of transverse and descending colon. This is why crohn’s can be misdiagnosed or completely missed in diagnosis. The ulcerative colitis occurs in the descending colon only.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the symptoms of IBD

A

Inflammation: swelling, redness - increased blood flow – increased temperature, pain. Pain when passing the stool. Redness is only notable inside the colon, but the other symptoms of inflammation are noticeable. Swollen sector can cause increase in pressure and distension, leading to blood in diarrhoea, loss of blood and weight loss follows.
What is the main difference? Site of infection. In CD there are skipped lesions but in UC the ulcers are present in the lower part in continuity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Diagnosis of CD vs UC

A

Crohn’s disease extends to all the muscles, and deeper layers of the intestinal wall. This leads to wall pipe thickening and the lumen is narrowed. There will be areas of abnormality and different textures within the length of the muscles (hard and soft).
In UC the ulceration is limited to the lining, but they are open, meaning they are connected to the lumen of the intestine. In an active phase they are red, but in an inactive they appear featureless. Every part of the GIT is inflamed.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the macroscopic features of CD vs UC

A

CD:
Transmural inflammation. Extends into the deeper layers of the intestinal wall. Bowell wall thickened and rigid (hosepipe thickening), lumen narrowed. Affected mucosa: fissuring and serpiginous ulcers. “Cobblestoning” Affected serosa: granular and fibrotic fat “wrapping”
UC:
Ulceration and inflammation of the inner lining of the colon and rectum. Characteristic ulcers or open sores. Active phase: mucosa red, friable, granular, oedematouse. Quiescent phase: mucosa atrophic and featureless

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How do genetics and environmental factors affect the prevalence?

A

Genetics: These affect the normal microbes in the large intestine.
Environmental factors: More meat is eaten in the areas where the is higher prevalence. Whereas areas in with lower prevalence eat more fibrous foods like potatoes and vegetables.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the symptoms and long-term complications of IBD? (slide 12)

A

Main ones: rectal bleeding, bloodied stool (due to stool rubbing against bloodied walls), diarrhoea, weight loss, fever, change in menstrual cycle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What affects pathogenesis of IBD?

A

The pathogenesis of IBD. Genetic, microbial, and environmental factors participate to disrupt normal microbes on the intestinal barrier. The defective mucosal integrity starts a complex vicious cycle that leads to, enhances, and perpetuates IBD.

Microbiota: Group of microorganisms that resides in a previously established environment. Dysbiosis is an unhealthy change in the normal microbiota.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What leads to IBD in simple terms?

A

Cells are so closely packed together there are no openings, it prevents the bacteria from entering the blood. Anything that disrupts this barrier leads to IBD. Along with this if microbial dysbiosis occurs it can cause IBD. Also defects in the number and function of Paneth cells, andincreased intestinal permeability can also result in increased bacterial exposure to the blood and muscles.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is involved in defective mucosal integrity?

A

Physical barrier

  • Mucus layer
  • Tight junctions

Specialised epithelial cells:

  • Goblet cells: mucus, repair & inflammation modulatory factors
  • Paneth cells: anti-microbial peptides (α-Defensins)

Mucosa Innate immune function:

  • Pattern recognition receptors (NOD - like receptors) that mediate responses to microbiota
  • Divert to tolerance or inflammation pathways
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the main events of intestinal inflammation?

A

Breakdown in mucosal barrier function. Lamina propria exposed to antigens
Infiltration with immune cells (Neutrophils, macrophages, dendritic cells, NK cells, B & T cells)
Local elevation of TNFα, IL-1β, IFNγ
T effectors differentiation: Local elevation of Th17 cells. Th1 raised in CD vs Th2 raised in UC. Th17 raised in both.
Defective regulation of immunosuppression (Tregs)
Chronic inflammation: Activated T cells activate other inflammatory cells like macrophages and B cells and recruit more inflammatory cells.
Good bacteria influenced by bad bacteria to turn bad.
T killer cells and macrophages kill cells in the viscinity.
NOD2 mutation affects paneth cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How is the muscle affected in CD vs UC?

A

All the muscles in CD are used and therefore it thickens, reducing the lumen.
In UC only the initial part of the lumen is affected so it forms polyps (projecting growth of tissue from a surface in the body) in those areas.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are some of the genetic problems with IBD?

A

Associated with 20% of IBD patients - 3-20 times higher incidence in first degree relatives.
Genetic influence is lower in UC than in CD

  • Defects in mucosal barrier: exposure to bacterial products. MUC19, OCTN, DLG5
  • Defects in bacterial sampling: Pattern recognition receptors Nod2 (CARD15) (bacterial peptidoglycan receptor), TLR (LPS receptor) – fails to recognise the bacteria is a normal flora
  • Defects in immune response: IL23R defect, IL-10 pathway, INFγ gene, Autophagy genes (ATG16L1)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are some environmental factors of IBD

A
  • Microorganisms
  • Diet
  • Infections
  • Stress
  • NSAIDs
  • Appendectomy
  • Smoking
  • Antiobiotics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

State the 4 phases of how impaired barrier function ends in tissue destruction and complications:

A

Phase 1: Impaired barrier function leads to transolcation of microbial products into the cells.
Phase 2: Leads to immune cell activation.
Phase 3: Pro-inflammatory mediators are produced due to activation of effector T cells. Macrophages also move to the infected area. There is also a failure in the regulatory mechanisms. This leads to chronic inflammation.
Phase 4: Produces fibrosis, stenosis, abscess, fistula, cancer, and extra-intestinal manifestations.

17
Q

What are the diagnosis and lab tests for IBD?

A

Laboratory tests – to remove other causes of the disease - starting point to rule out infectious causes; Stool cultures, Ova & Parasites Campylobacter, Salmonella, Shigella, C. difficile, etc.
Endoscopy
Radiography
Biopsy

18
Q

Describe the lab tests done for IBD:

A
  • Hemogram:
    - C-reactive protein is increased
    - ESR is increased
    - Platelet count increases
    - Haemoglobin decreases
    - Leads to leukocytosis
  • Faecal calponectin: Correlate with histological inflammation (predicts relapses)
  • IBD antibodies:
    - pANCA: Antineutrophil cytoplasmic antibody (don’t memorise this bs)
    - ASCA: Antisaccharomyces cerevisiae antibody (dont memorise)

Positive pANCA and negative ASCA suggests UC
Negative pANCA and positive ASCA suggest CD

19
Q

Sigmoidoscopy vs colonoscopy:

A

Both are types of endoscopy, sigmoido only goes to the sigmoid colon, where as colono reaches the start of the ascending colon.
Doing a sigmoido can lead to misdiagnosis of CD or even skipped diagnosis more so than UC due to the skipped lesions in CD. The camera may not reach past the rectum and therefore misses the inflammation.
This is important as CD can become chronic but UC symptoms pass eventually.

20
Q

What are the potential developments of IBD?

A

If not treated it can become cancerous, and the cancer will proliferate quickly as there is plentiful blood supply in the intestines.
Damage to the intestines can cause sepsis as the bacteria can enter the blood stream.
Main blood loss symptoms are: loss of weight, lethargy, anorexia from not wanting to eat.

21
Q

What are the pharmacological treatments of IBD?

A

ANTIBIOTICS
 Metronidazole
 Ciprofloxacin

PROBIOTICS
 E. coli Nissle 1917
 VSL#3

ANTIINFLAMMATORY
 Aminosalycilates
 Glucocorticoids

BIOLOGICALS
 Infliximab
 Adalimumab
 Ustekinumab
 Vedolizumab
 Tofacitinib
IMMUNOSUPRESANTS
Azathioprine
6-mercaptopurine
 Methotrexate
 Cyclosporine
22
Q

How do aminosalycilates work as anti-inflammatory drugs?

A

Treatment of active UC
 Maintenance therapy in UC patients

Mechanism of Action: activation of PPARy
• Inhibit eicosanoid synthesis (LTB4, TXA2, PGE2?)
• Inhibit production of proinflammatory cytokines (IL-1, TNF…)
• Inhibit adhesion molecule expression (stops sticking to walls of intestine)
• Stimulates production of anti-inflammatory molecules.
• Modulates proliferation, differentiation and survival of immune cells

5-ASA combinations, that release 5-asa in the colon. Local action due to poor gut absorption
Sulfasalazine (5-aminosalicylic acid + sulfapyridine)
Mesalazine (5-ASA)
Olsalazine (5-ASA dimer cleaves in colon)
Balsalazide (a pro-drug of 5-aminosalicylic acid)

23
Q

How do glucocorticoids work?

A

Moderate to severe relapses (active UC and CD).

Mechanism of action: Modify gene transcription

Inhibition of inflammatory pathways:
• Inhibit production of proinflammatory cytokines (IL-1, TNF, IL-8, IL-6…)
• Inhibit systhesis of proinflammatory enzymes (COX-2,
iNOS, PAF synthetase, colagenase…)

Budesonide, Prednisone

24
Q

How do immunosuppressants work?

A

Thiopurines (Azathioprine, 6-mercaptopurin)
Mechanism of action: Inhibit T cell and B cell proliferation

Methotrexate
Mechanism of action: Inhibit production of proinflammatory mediators

Cyclosporin
Mechanism of action: Inhibit synthesis of IL-2 and IL-2R, inhibiting clonal expansion of Tcells

 Maintenance therapy in CD and in UC if treatment escalation required.
 Steroid sparing (maintenance CD)
 Active CD

25
Q

How do biological (anti-TNF agents) drugs work?

A

Anti-TNF agents: Infliximab, Adalimumab, Golimumab
 Extensive/ Severe active CD and fistulizing CD
 Maintenance refractory/intolerant to immunosuppression

Infliximab:
• Binds to TNF trimers, preventing cytokine from binding to its receptors
• Binds to membrane-bound TNF- a and neutralizes its activity
• Reduces serum TNF levels.

Monoclonal antibodies  against TNF
TNFα:
- Induces proinflammatory cytokines release (IL-1, IL-6)
- Activates leukocyte migration
- Inhibits inflammatory cells apoptosis
26
Q

How do antibiotics work?

A

Antibiotics: Metronidazole (bacteriocidal) and Ciprofloxacin (bacteriostatic)
Pouchitis
- Patients with UC and toxic megacolon
- Treatment of active fistulous & perianal CD

Minocycline is an immunomodulatory antibiotic

27
Q

How do probiotics and prebiotic fibers work?

A

Probiotics
A preparation containing, viable, defined microorganisms in sufficient numbers to alter the microbiota by implantation or colonization in a compartment of the host, and exert beneficial effects on host health.

Prebiotics: Fibers
Indigestible carbohydrates, which stimulate the growth of particular species of the microbiota of the host, resulting in an better enteric function